{
    "Trade/Device Name(s)": [
        "Etest\u00ae Ceftaroline"
    ],
    "Submitter Information": "bioM\u00e9rieux SA",
    "510(k) Number": "K151873",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121002"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JWY"
    ],
    "Summary Letter Date": "June 30, 2015",
    "Summary Letter Received Date": "July 9, 2015",
    "Submission Date": "June 30, 2015",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Streptococcus pneumoniae",
        "Streptococcus agalactiae",
        "Haemophilus influenzae",
        "Staphylococcus aureus"
    ],
    "Specimen Type(s)": [
        "Bacterial isolate"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Dilution and diffusion gradient",
        "Agar incubation"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "MIC determination"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Strip test"
    ],
    "Document Summary": "FDA 510(k) summary for Etest\u00ae Ceftaroline quantitative antimicrobial susceptibility strip for Gram-positive and Gram-negative aerobic and fastidious bacteria.",
    "Indications for Use Summary": "Quantitative determination of antimicrobial susceptibility of aerobic and fastidious bacteria (including Streptococcus pneumoniae, Streptococcus agalactiae, Haemophilus influenzae, and Staphylococcus aureus) using a predefined antibiotic gradient on agar media.",
    "fda_folder": "Microbiology"
}